相关实验视频

Updated: May 14, 2025

Improving IV Insulin Administration in a Community Hospital

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

胰岛素APP十年:使用COSMIN的验证及其最初出版以来的临床进展

Marcos Tadashi Kakitani Toyoshima^1,2, Julia Mandaro Lavinas-Jones^3,4, Alina Coutinho Rodrigues Feitosa^3,4

¹Department of Endocrinology and Metabolism, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil. marcos.tadashi@hc.fm.usp.br.

Diabetology & metabolic syndrome

|May 10, 2025

概括

电子血糖管理系统 (eGMS) InsulinAPP已在10年内被验证用于住院胰岛素治疗. 它证明了科学稳定性和现实世界的适用性,改善了血糖控制和安全性.

科学领域:

医疗信息学医疗信息学
临床决策支持临床决策支持
糖尿病管理糖尿病管理

背景情况:

胰岛素APP是一种巴西电子血糖管理系统 (eGMS),用于住院胰岛素治疗,协助非专业医生.
该系统已经在十年内发展成为一个经过验证的临床决策支持工具,具有经过证明的影响.
本稿详细介绍了使用COSMIN框架在五个核心领域进行的InsulinAPP的验证.

研究的目的:

*使用COSMIN框架对InsulinAPP的验证进行结构化概述.
* 评估其跨文化适应性,内容有效性,标准有效性,可靠性和构造有效性.
* 确认该工具的科学可靠性,安全性和实际应用性.

主要方法:

*使用COSMIN框架在五个核心领域进行验证.
* 可用性测试,以评估用户接受度.
* 一个随机试验,比较InsulinAPP引导的护理与内分泌学家领导的护理.

主要成果:

*高可用性接受度 (平均利克特得分为4.8/5) 和强大的内容有效性 (CVI = 0.95).
*高可复制性 (ICC = 0.98) 和可比的血糖控制与低低血糖率的专家护理相比.
*简单性,EHR独立性,以及适应低资源环境的优势.

结论:

* 胰岛素APP是用于住院患者血糖管理的科学合理和安全工具.
*其协议与主要内分泌学会的最新指导方针保持一致.
*建议进行更广泛的实施和多中心研究,以进一步探索其影响.

关键词:

这是Cosmin验证的结果.构建有效性构建有效性糖尿病是一种糖尿病.数字健康工具数字健康工具电子血糖管理电子血糖管理血糖管理系统的管理系统.预防低血糖的预防住院患者的血糖控制胰岛素APPAPP的使用方法非专业医生是非专业医生.

更多相关视频

An In Ovo Model for Testing Insulin-mimetic Compounds

An In Ovo Model for Testing Insulin-mimetic Compounds

Published on: April 23, 2018

Homogeneous Time-resolved Förster Resonance Energy Transfer-based Assay for Detection of Insulin Secretion

Homogeneous Time-resolved Förster Resonance Energy Transfer-based Assay for Detection of Insulin Secretion

Published on: May 10, 2018

相关概念视频

Insulin: Dosing Regimen and Adverse Effects

Insulin: Dosing Regimen and Adverse Effects

Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...

Insulin: Biosynthesis, Chemistry, and Preparation

Insulin: Biosynthesis, Chemistry, and Preparation

The endoplasmic reticulum (ER) of pancreatic β-cells synthesizes preproinsulin, which consists of a signal peptide, A and B chains, and a C-peptide. Preproinsulin is then cleaved and folded into proinsulin, which translocates to the Golgi apparatus for sorting and packaging into secretory granules. In these granules, enzymatic clipping generates insulin and C-peptide.
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment...

Insulin: The Receptor and Signaling Pathways

Insulin: The Receptor and Signaling Pathways

Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but...